Discovery Platform –Symbiont®
Bioinformatic Capabilities for Microbiome Ingredient Development and Product Formulation
- Symbiont® is Biohm Technologies’ systematic approach to ingredient discovery, selection and formulation with our proprietary dataset at its core. This cutting-edge technology is used to identify and select optimal ingredients for microbiome-based supplement products.
Driven By Data
Biohm’s unique microbiome dataset, including bacterial and fungal strains, is the largest of its kind in the world, and has continued to collect data on tens of thousands of consumers (and counting) since the inception of the company’s at-home gut microbiome health test kits in 2018.
The deep insights into the human microbiome uncovered by this data are at the core of the Symbiont discovery platform
AI-Powered Microbiome Innovation
Further enhancing Symbiont’s functionality, Biohm has recently partnered with Virginia Tech to incorporate artificial intelligence (AI) tools, which yield profound predictive capabilities.
Through this game-changing platform, we aim to revolutionize ingredient discovery and formulation capabilities for microbiome focused dietary supplement product developers.
Peer Reviewed and Validated
The Symbiont approach has been peer reviewed with a published paper in Gastroenterology on the use of microbiome fungal and bacterial data as a novel product development methodology for creating innovations in the nutraceutical industry.